046 Group 1 vs Group 4: P = 0
Common side effects are gastrointestinal, such as nausea, vomiting, diarrhea, and constipation, especially when treatment begins or the dose increases
However, if your appetite is very low, even 20 to 25 grams per meal is a win
This material may not be published, broadcast, rewritten or redistributed without permission.
A more convenient option A new obesity treatment comes as a standard pill
Things to Keep in Mind Wegovy is preferred on most Aetna plans CVS Caremark made it their primary GLP-1 in July 2025 Prior authorization is required you'll need to meet BMI and documentation criteria If denied, file an appeal 65%+ of appealed denials are overturned when properly documented [5] Cardiovascular benefit strengthens your case Wegovy is FDA-approved to reduce heart attack/stroke risk (March 2024) If your PA is denied, don't give up most denials can be overturned with the right documentation